| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRNA | Common Stock | Options Exercise | $327K | +2.41K | +0.15% | $135.80 | 1.63M | May 27, 2022 | Direct | F1 |
| transaction | MRNA | Common Stock | Options Exercise | $7.36K | +7.43K | +0.46% | $0.99* | 1.63M | May 31, 2022 | Direct | F2 |
| transaction | MRNA | Common Stock | Sale | -$145K | -999 | -0.06% | $145.40 | 1.63M | May 31, 2022 | Direct | F3 |
| transaction | MRNA | Common Stock | Sale | -$1.08M | -7.43K | -0.46% | $144.97 | 1.62M | May 31, 2022 | Direct | F2 |
| holding | MRNA | Common Stock | 4.12K | May 27, 2022 | By Valhalla, LLC | ||||||
| holding | MRNA | Common Stock | 152K | May 27, 2022 | By Trust | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRNA | Restricted Stock Units | Options Exercise | $0 | -2.41K | -12.5% | $0.00 | 16.9K | May 27, 2022 | Common Stock | 2.41K | $0.00 | Direct | F1, F5 |
| transaction | MRNA | Stock Option (Right to Buy) | Options Exercise | $0 | -7.43K | -100% | $0.00* | 0 | May 31, 2022 | Common Stock | 7.43K | $0.99 | Direct | F2, F6 |
| Id | Content |
|---|---|
| F1 | Restricted stock units convert into common stock on a one-for-one basis. |
| F2 | The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. |
| F3 | Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
| F4 | These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. |
| F5 | 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter. |
| F6 | This option is fully vested and exercisable. |